HIMS

44.39

2.35% -1.07

Handel nachbörslich: 46.90 2.51 +5.65%

Hims Hers Health Inc (HIMS)

Überblick Nachrichten Preisverlauf Optionskette Financials Warum fällt HIMS? Forum Prognose

Schlusskurs vom Vortag:

$45.46

Offen:

$46.9

24-Stunden-Volumen:

38.33M

Relative Volume:

1.34

Marktkapitalisierung:

$9.66B

Einnahmen:

$1.78B

Nettoeinkommen (Verlust:

$164.40M

KGV:

64.33

EPS:

0.69

Netto-Cashflow:

$236.51M

1W Leistung:

-7.96%

1M Leistung:

-15.51%

6M Leistung:

+8.75%

1J Leistung:

+118.03%

1-Tages-Spanne:

$44.01

$47.15

1-Wochen-Bereich:

$44.01

$49.17

52-Wochen-Spanne:

$19.15

$72.98

Hims Hers Health Inc Stock (HIMS) Company Profile

Firmenname

Hims Hers Health Inc

Sektor

Healthcare (1136)

Branche

Drug Manufacturers - Specialty & Generic (85)

Telefon

415-851-0195

Adresse

2269 CHESTNUT ST, SAN FRANCISCO

Mitarbeiter

1,637

Twitter

Nächster Verdiensttermin

2025-02-24

Neueste SEC-Einreichungen

HIMS's Discussions on Twitter

Vergleichen Sie HIMS mit anderen Aktien

Aktien	Preis	Marktkapitalisierung	Umsatz	Nettogewinn	Free Cashflow	ENV
HIMS Hims Hers Health Inc	44.39	10.27B	1.78B	164.40M	236.51M	0.69
ZTS Zoetis Inc	144.35	63.86B	9.39B	2.62B	2.22B	5.8121
TAK Takeda Pharmaceutical Co Adr	13.42	42.46B	29.96B	957.25M	4.77B	0.2956
HLN Haleon Plc Adr	9.38	41.28B	14.26B	1.98B	2.47B	0.4327
TEVA Teva Pharmaceutical Industries Ltd Adr	20.52	23.49B	16.70B	-157.13M	1.19B	-0.1446
UTHR United Therapeutics Corp	438.66	19.18B	3.08B	1.24B	1.07B	25.61

Hims Hers Health Inc Stock (HIMS) Upgrades & Downgrades

Datum	Aktion	Analytiker	Ratingänderung
2025-10-21	Eingeleitet	KeyBanc Capital Markets	Sector Weight
2025-06-23	Herabstufung	Needham	Buy → Hold
2025-06-04	Bestätigt	Needham	Buy
2025-04-29	Herabstufung	TD Cowen	Buy → Hold
2025-02-18	Herabstufung	Morgan Stanley	Overweight → Equal-Weight
2025-01-10	Herabstufung	Citigroup	Neutral → Sell
2025-01-07	Eingeleitet	BTIG Research	Buy
2024-12-17	Eingeleitet	Morgan Stanley	Overweight
2024-11-14	Herabstufung	BofA Securities	Buy → Underperform
2024-08-22	Eingeleitet	Needham	Buy
2024-08-09	Herabstufung	Imperial Capital	Outperform → In-line
2024-05-22	Herabstufung	Citigroup	Buy → Neutral
2024-04-16	Herabstufung	Jefferies	Buy → Hold
2024-04-10	Eingeleitet	Canaccord Genuity	Buy
2024-02-28	Hochstufung	Imperial Capital	In-line → Outperform
2024-02-26	Eingeleitet	Leerink Partners	Market Perform
2023-12-07	Eingeleitet	Imperial Capital	In-line
2023-07-28	Eingeleitet	TD Cowen	Outperform
2023-04-11	Eingeleitet	Robert W. Baird	Neutral
2023-02-09	Hochstufung	Jefferies	Hold → Buy
2022-11-08	Hochstufung	BofA Securities	Neutral → Buy
2022-11-08	Hochstufung	SVB Leerink	Mkt Perform → Outperform
2022-10-17	Herabstufung	Piper Sandler	Overweight → Neutral
2022-09-07	Eingeleitet	Truist	Hold
2022-07-15	Eingeleitet	SVB Leerink	Underperform
2022-04-14	Eingeleitet	Guggenheim	Buy
2022-04-01	Fortgesetzt	Credit Suisse	Outperform
2022-03-10	Eingeleitet	Deutsche Bank	Hold
2021-12-02	Eingeleitet	Jefferies	Hold
2021-11-11	Hochstufung	Piper Sandler	Neutral → Overweight
2021-07-06	Eingeleitet	BofA Securities	Neutral
2021-05-20	Hochstufung	Credit Suisse	Neutral → Outperform
2021-04-21	Eingeleitet	Truist	Hold
2021-03-09	Eingeleitet	Credit Suisse	Neutral
2021-03-02	Hochstufung	Citigroup	Neutral → Buy
2021-02-17	Eingeleitet	Citigroup	Neutral
2021-02-12	Eingeleitet	Piper Sandler	Neutral
2021-02-08	Eingeleitet	Tigress Financial	Buy

Alle ansehen

Hims Hers Health Inc Aktie (HIMS) Neueste Nachrichten

06:42 AM

Hims and Hers tops revenue estimates as telehealth provider attracts more users - Reuters

06:42 AM

06:30 AM

Earnings call transcript: Hims & Hers Health Q3 2025 misses EPS, stock rebounds - Investing.com

06:30 AM

06:23 AM

Novo Nordisk’s Wegovy could soon have a new sales outlet in the U.S. - MarketWatch

06:23 AM

06:21 AM

Hims & Hers Health (HIMS) Surges After Hours on Robust Q3 and Renewed Novo Nordisk (NVO) Wegovy Talks - FinancialContent

06:21 AM

05:40 AM

Hims & Hers Health in discussions with Novo Nordisk to sell Wegovy - Seeking Alpha

05:40 AM

05:38 AM

Hims & Hers Health Third-Quarter Revenue Jumps as Subscribers Grow - The Wall Street Journal

05:38 AM

05:16 AM

Hims & Hers Health rises after narrowing 2025 EBITDA guidance, Q3 EPS miss - Seeking Alpha

05:16 AM

05:15 AM

After-hours movers: Palantir, Hims & Hers Health, Sarepta Therapeutics, Sanmina - Investing.com Canada

05:15 AM

05:13 AM

Hims & Hers Health (NYSE:HIMS) Issues Quarterly Earnings Results, Meets Expectations - MarketBeat

05:13 AM

05:05 AM

Hims & Hers Health Q3 revenue tops estimates as subscriber growth jumps - Investing.com Australia

05:05 AM

05:04 AM

Hims Shares Rise on Talks to Offer Novo’s New Obesity Pill - Bloomberg.com

05:04 AM

05:03 AM

Hims & Hers Health Q3 revenue tops estimates as subscriber growth jumps By Investing.com - Investing.com South Africa

05:03 AM

04:54 AM

Earnings live: Palantir stock rises modestly on strong results, Hims & Hers stock surges - Yahoo Finance

04:54 AM

04:53 AM

Hims and Hers beats revenue estimates on strong subscriber growth - Yahoo Finance

04:53 AM

04:35 AM

Stock Market Today: Palantir, Vertex, and Hims & Hers Report After the Closing Bell - TheStreet

04:22 AM

04:19 AM

Hims and Hers misses quarterly profit estimates - Yahoo! Finance Canada

04:19 AM

04:14 AM

Hims rises on revenue beat, discloses it’s again in partnership talks with Novo - Sherwood News

04:14 AM

04:11 AM

Hims and Hers Beats Revenue Estimates on Strong Subscriber Growth - US News Money

04:11 AM

04:10 AM

Earnings Flash (HIMS) Hims & Hers Health, Inc. Reports Q3 Revenue $599.0M, vs. FactSet Est of $580.2M - MarketScreener

04:10 AM

04:08 AM

How we’re reaching more customers with a new standard of care - Hims & Hers Newsroom

04:08 AM

03:27 AM

Notable Monday Option Activity: PFGC, GRPN, HIMS - Nasdaq

03:27 AM

12:24 PM

Hims & Hers Q3 Preview: GLP-1 Drug Expansion Draws Investor Focus - Stocktwits

12:24 PM

11:33 AM

PREVIEW: Hims & Hers dips; focus on weigth-loss drug - TradingView

11:33 AM

11:28 AM

Hers Health, Inc. Reports Third Quarter 2025 Financial Results - Hims Investor Relations

11:28 AM

08:22 AM

Stock Market Today: Dow Jones, Nasdaq Futures Rise After Stellar October Gains— Micron Technology, Palantir, Hims & Hers In Focus (UPDATED) - Benzinga

08:22 AM

07:01 AM

Hims & Hers Stock Seeks Support as Earnings Casts a Shadow - AskTraders.com

07:01 AM

06:32 AM

Intellectus Partners LLC Buys Shares of 61,036 Hims & Hers Health, Inc. $HIMS - MarketBeat

06:32 AM

06:22 AM

7,345 Shares in Hims & Hers Health, Inc. $HIMS Purchased by W.G. Shaheen & Associates DBA Whitney & Co - MarketBeat

06:22 AM